Antiplatelet Medications in Hemodialysis Patients: A Systematic Review of Bleeding Rates

AUTOR(ES)
FONTE

American Society of Nephrology

RESUMO

Background and objectives: Patients with end stage renal disease (ESRD) are often prescribed antiplatelet medications. However, these patients are also at increased risk of bleeding compared with the general population, and an aim was made to quantify this risk with antiplatelet agents.

ACESSO AO ARTIGO

Documentos Relacionados